The adaptor protein Lnk modulates endothelial cell activation;La protéine adaptatrice Lnk module l'activation des cellules endothéliales

Nephrologie et Therapeutique

Volumn 1, Issue 4, 2005, Pages 228-233

  Fitau, Juliette ^a   Boulday, Gwénola ^a   Coulon, Flora ^a   Charreau, Béatrice ^a  

^a HÔTEL DIEU   (France)

Author keywords

Endothelial cells; Inflammation; Lnk intracellular signalling; PI3 kinase

Indexed keywords

ADAPTOR PROTEIN; I KAPPA B ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN LNK; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADENOVIRUS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 27644535730     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2005.06.010     Document Type: Article

References (14)

1. Kubo-Akashi C, Iseki M, Kwon SM, Takizawa H, Takatsu K, Takaki S. Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly. Biochem Biophys Res Commun 2004;315:356.
2. Huang X, Li Y, Tanaka K, Moore KG, Hayashi J. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995;92:11618.
3. Takaki S, Watts JD, Forbush KA, Nguyen NT, Hayashi J, Alberola-Ila J, et al. Characterization of Lnk. An adaptor protein expressed in lymphocytes. J Biol Chem 1997;272: 14562.
4. Li Y, He X, Schembri-King J, Jakes S, Hayashi J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000;164:5199.
5. Takaki S, Sauer K, Iritani BM, Chien S, Ebihara Y, Tsuji K, et al. Ms. Control of B cell production by the adaptor protein Lnk. Definition of a conserved family of signal-modulating proteins. Immunity 2000;13:599.
6. Rudd C. Es. Lnk adaptor: novel negative regulator of B cell lymphopoiesis. Sci STKE 2001; 2001: PE1.
7. Takaki S, Tezuka Y, Sauer K, Kubo C, Kwon SM, Armstead E, et al. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J Immunol 2003;170:703.
8. Tong W, Lodish H. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004;200: 569.
9. Boulday G, Coulon F, Fraser CC, Soulillou JP, Charreau B. Transcriptional up-regulation of the signaling regulatory protein Lnk in activated endothelial cells. Transplantation 2002;74:1352.
10. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509.
11. Pober J. Endothelial activation: intracellular signaling pathways. Arthritis Res 2002;4(Suppl 3):S109.
12. Madge LA, Pober J. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkB in human endothelial cells. J Biol Chem 2000;275:15458.
13. Gerritsen ME, Bloor C. Endothelial cell gene expression in response to injury. FASEB J 1993;7:523.
14. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner D. NFkB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82.